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The goals of the present study were: (1) to investigate thc binding properlies oi (R)- and (S)-procyclidine and two 
aehiral derivatives of muscarinie M1• M2 and M4 reeeptor subtypes and (2) to identify the interaetions which allow 
these receptors to diseriminate between the two stereoisomers. (R)-Procyclidine showed a higher affinity for human 
neuroblastoma NB-OK 1 muscarinie M 1 and rat striatum musearinie M 4 receptors. a~ compared to rat cardiac M 2 
receptors. (S)-Procyclidine had a 130-iold lower affinity than (R)-procyclidine for M 1 and M 4 receptors. and a 40-fold 
lower affinity for M 2 receptors. Pyrrinol. the aehiral diphenyl derivative with the eyclohexyl g.roup of (S}-procyclidine 
replaeed by a phenyl group, has an eight-fold lower affinity for M1 and M4 receptors. as eompared to (R)-procycli-
dine, and a three-fold lower affinity for M 2 receptors. Hexahydro-procyclidine. the eorresponding achiral dicyclohexyl 
compound, had a 10- to 20-fold lower affinity than (R)-procyclidine for the three reeeptors. 
The inerease in binding free energy, which is observed when the phenyl and eyclohexyl groups of procyelidine are 
separately replaeed by cyclohexyJ and phenyl groups, respectively. was additive in the ease of M 1• M 2 and M4 
receptcrs. This indicates that the musearinic reeeptor s!ereoseleetivity was based on the eoexistence of two binding 
sites, one preferring a phenylrather than eyclohexyl group and the seeond preferring a cyclohexyl rather than a phenyl 
group. In addition. there were aiso binding sites for the hydroxy moiety and the protonated amino group of the 
ligands. The greater affinity and stereoselectivity of M1 and M4 musearinic receptors for (R)-procyelidine reflected the 
better fit of the eyclohexyl group of (R)-procyclidine to the subsite of M 1 and M 4 as compared to M 2 receptors. 
Musearlnie M, reeeptors; Muscarinie M2 reeeptors; Musearinic M4 receptor~~ (S}-Procyelidine; (R)-Procyclidine; 
Pyrrinol; Hexahydro-procyclidine; Musearlnie receptors (stereose1ecti\ity) 
1. Introduction 
At least four pharmacoiogically and biochem-
ically distinct muscarinic receptors coexist in 
mammalian tissues (for review: see Mitchelson, 
1988; Levine and Birdsall, 1989): (a) M1 recep-
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tors, with a high affinity for pirenzepine, are typi-
cally found in neuronal tissues (Hammer et al., 
1980). These receptors also have a high affinity for 
4-DAMP ( 4-diphenylacetoxy-N-mcthylpiperidi••e 
methiodide) and HHSiD (hexahydro-sila-difen·· 
idol) but a low affinity for AF-DX 116 ([11-({(2-
[ ( diethylamino )methyl ]-1-pi peridinyl} acetyl)-5.11-
dihydro-6 H·pyrido-(2,3-b) ( 1 ,4 )-benzodiazepin-6-
one) (Waelbroeck et al.. 1987b; 1988; 1989); (b) 
M 2 receptors, wilh a high affinity for AF-DX 116 
and a low affinity for pirenzepine are especially 
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present in cardiac tissue (Hammer et al.7 1986). 
They also show a low affmity for 4-DAMP and 
HHSiD (Waelbroeck et al., 1987b; 1988; 1989); 
(c) M3 receptors have high affinities for 4-DAMP 
(Barlow et al., 1976) and HHSiD (Mutschler and 
Lambrecht, 1984) and low affinities for pirenze-
pine and AF-DX 116. They are typically detected 
in secretory glands and smooth muscle (Wael-
broeck et al., 1987a; Kore et al., 1987); (d} M 4 
r~eptors are typically found in NG 108-15 cells 
(Michel et al., 1989) and rat striatum (Waelbroeck 
e~ al., 1990). They have low affinities for pirenze-
pipe and AF!'DX 116 but high affinities for 
m~~hoctramin~ and HHSiD. 
We previously demonstrated that receptors 
Iabeted by [3H]-N-methylscopolamine ([ 3H]NMS) 
in NB-OK 1 cells (a human neuroblastoma cell 
line), rat heart, and rat striatum (those receptors 
showing slow [3H]NMS dissociation) display M1, 
M 1 and M 4 selectivities, respectively (Waelbroeck 
et al., 1986; 1987a,b; 1988; 1989; 1990). We de-
cided to compare these three systems to an~yze 
the structure-affinity jselectivity relationships of 
musearlnie antagonists related to procyclidine. 
A majority of previous studies comparing the 
binding or functional properlies of chiral 
musearlnie antagonists and agonists used the drugs 
as racemates. While this is sometimes unavoidable 
( fot example if the drug racemizes quickly in 
solution), there are important drawbacks in utiliz-
ing a racemate rather than the individual enanti-
omers (see for example: Lambrecht and Mutschler, 
1986; Lambrecht et al., 1988; Tacke et al., 1986; 
1987; 1989; and the Series on Chirality (published 
in Trends Pharmacol. Sei. 7, 1986, 20-24, 60-65, 
112-115, 155-158, 200-205, 227-230, 281-301). Re-
ceptors are indeed asymmetrical macromolecules. 
When studying the binding or functional proper-
lies of a racemic mixture of compounds, the infor-
mation bears at best on the eutomer (high-affinity 
enantiomer) but the properties are in some cases 
affected by the presence of the distomer (low-af-
finity enantiomer). If the absolute configuration of 
the eutomer is not known, it is, for example, 
impossible to map the relative positions of recep-
tor 'subsites' recognizing the protonated amino 
group and the hydroxyl group of antimuscarinics 
of the procyclidine type family. 
0 
HO~~ - CH2 - CH2 - 0 
~ !Sl-PROCYCLIO!NE 
9 
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HO - C - CH2 - CH2 - 0 6 HEXAHYOAO-PROCYCllOlNE 
Fig. 1. Chemical structure of (S}-procy.;lidine, (R)-procycli-
dine, pyrrinol and hexahydro-procyclidine. ln the case of (S)-
and (R)-procyclidine, the carbinol carbon atorn is a center of 
chirality. 
The first aim of the present study was to com-
pare the binding properties of (R)- and (S)-pro-
cyclidine to the three reasonably pure musearlnie 
receptor systems at band. The affinity and stereo-
selectivity of 1\'j ,, M 2 and M4 receptors for pro-
cyclidine enantiomers proved to be different in 
our binding experiments. In order to identify the 
interactions responsible for musearlnie receptor 
stereoselectivity, we extended the binding analysis 
to two achiral compounds structurally related to 
(R)- and (S)·procyclidine: pyrrinol (the diphenyl 
derivative) and hexahydro-procyclidine (the di-
cyclohexyl derivative). The structures of these 
compounds are shown in fig. 1. 
2. Materials and methods 
2.1. Human NB-OK 1 neurob/astoma cel/s 
The NB-OK 1 cells were cultured as previously 
described (Waelbroeck et al., 1988) in RPMI-1640 
medium enriched with 10% fetal calf serum~ 100 
unitsjrnl p~nicillin and 100 p.gjml Streptomycin. 
F or 1-[N -rr:ethyl- 3H]scopolomine methyl chloride 
([ 3H]NMS) binding experiments, the cells were 
rinsed, detached and centrifuged in 20 mM sodium 
phosphate buffer (pH 7 .4) containing 150 mM 
NaCl and 1 mM EDTA, resuspended and ho-
mogenized in 20 mM TrisjHCl buffer (pH 7.5) 
enriched with 5 mM MgCl2 and stored in liquid 
nitrogen until use. 
2.2. Rat tissue homogenate prepar~uions 
Male Wistar albino rats (200-250 g) were de-
capited and the heart and striatum immediately 
removed. All following operations were performed 
at 4°C. 
The heart was rinsed in isotonic N aCI, then 
homogenized in 2.5 ml of 20 m~.f TrisjHCl buffer 
(pH 7.5), enriched with 250 mM sucrose, with an 
Ultraturrax homogenizer (maximal speed for 5 s) 
followed by addition of 12.5 ml of the same buffer, 
seven up and down strokes with a glass-Teflon 
hornogenizer and filtration on two layers of medi-
cal gauze. The resulting homogenate was used 
inunediately or stored in liquid nitrogen until use. 
The striatum was homogenized in 2 ml of 20 
mM TrisjHCI buffer (pH 7.5) enriched with 250 
mM sucrose~ using a glass-Teflon homogenizer 
(seven up and down strokes). The resulting homo-
genate was stored in liquid nitrogen until use and 
diluted 20-fold with the same buffer immediately 
before the experiment. 
The protein concentrations were determ.ined 
according to Lowry· et al. (1951) using bovine 
serum albunlin as Standard. 
2. 3. Binding studies 
All binding studies were performed at 25 ° C, at 
equilibrium, in a 50 ml'vf sodium phosphate buffer 
(pH 7.4) enriched with 2 mM MgCl2, [ 3H]NMS, 
and the indicated unlabeled dtug concentrations, 
in a total volume of 1.2 ml. 
To measure [3H]NMS binding to human NB-
OK 1 cell homogenates, we used 80 111 of homc--
genate, corresponding to about 200 1-'8 protein per 
assay. The incubation period was 2 h in the pres· 
ence of 0.25 nM [3H}NMS (this concentration was 
equivalent to two-fold the tracers' K 0 value to M1 
receptors). 
For incubation with rat heart homogenates, we 
used 80 1.d of the homogenate, corresponding to 
400-500 pg protein per assay. The 2 h incubation 
period was sufficient to allow equilibrium binding. 
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The eHJNMS concentration used was 1.0 nM, i.e. 
two-fold the tracers' K0 value to M2 bi.nding sites. 
In rat striatum homogenates, ( 3H]NMS Iabels 
M1 and M4 sites but dissociates faster from M 1 
receptors (Waelbroeck et al., 1986. 1987b, 1988). 
We preincubated 80 f.d of the homogenate (equiv-
alent to about 30 p.g protein) in a total volume of 
t.2 ml, in the presence of [3H]NMS and unlabeled 
drugs. A 2 h preincubation period allowed equi-
librium binding. We then added 1 p.M atropine 
and allowed tracer dissociation !or ~5 m.in before 
filtration. This procedure allowed us to investigate 
tracer binding to striatum M 4 receptors only 
(Waelbroeck et al., 1987b; 1988; 1990}. The tracer 
concentration used in these experiments (0.25 nM} 
was equivalent to five·fold the tracers9 K0 value to 
striatum M4 receptors (Waelbroeck et al., 1988). 
All incubations were terminated by addition of 
2 ml of ice-cold filtration buffer (50 mM sodium 
phosphate buffer pH 7.4}. Bound and free tracer 
were immediately separated by fihration on GF ;c 
glass-fiber filters presoaked ovem.ight in 0.05% 
polyethyleneimine. The samples were rinsed three 
times wit~ filtration buffer. The filters were then 
dried and the bound radioactivity counted by 
liquid scintillation. Nonspecific [3H]NMS binding 
was defined as tracer bound in the presence of 1 
~tM atropine. 
2.4. Analysis of binding data 
All competition curves were repeated in dupli-
catet on at least three different preparations. ICso 
values were determined by a computer-aided pro-
cedure described by Richardson and Humrich 
(1984), assuming the existence of only one recep-
tor subtype. Indeed, experimental data points were 
within 3% of expected values~ assuming that the 
molecules investigated competed with eHJNMS 
for binding to a single site. 
Ki values were calculated from IC50 va1ues using 
the Cheng and Prusoff equation (Cheng and 
Pntsi:>ff. 1973) which assumes competitive inhibi-
tion of tracer binding to a single receptor subtype~ 
The [3H]NMS K 0 value for the three systems 
investigated was determined in separate experi· 
ments, as described by Waelbroeck et al. (1987a.b; 
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1988). The pKi values, mentioned in table 1, cor-
responded to -log Ki values. 
The standard deviation of piCso (-log IC5o) 
determinations was always equal to or below 0.1 
log unit. Repeated determinations of [3H]NMS 
K 0 values were within 10% of each other. 'fhis 
error should be added to errors in IC50 determina-
tions, since [3H]NMS K 0 values were used to 
calculate pKi values. We therefore estimated the 
standard deviation of pK i values as being of ap-
proximately 0.15 log unit (40% of Ki value). 
The binding free energy (.:1G) for the formation 
of a Iigand-receptor complex is related to i~s affin~ 
ity constn.nt Ka by equation (1): 
ßG= -RTln Ka (1) 
.dG values were therefore calculated according 
to equation (2), using experimentally determined 
Ki values (Ka = Kj 1): 
.:1G = - RT In 1/Ki (2) 
2.5. Materials 
[ 3H]NMS (80 to 85 Cijrnmol) was obtained 
from Amersham International (Bucks, England). 
Atropine sulfate and polyethyleneimine were from 
Sigma Chemical Co. (St Louis, MO, U .S.A.), and 
GF ;c glass-fiber fdters from Whatman (Maid-
stone, England). All the others reagents were of 
the highest grade available. All antagonists tested 
were synthesized in our laboratories: the pro-
cyclidine enantiomers were prepared as previously 
TADLE 1 
published (Tacke et al., 1986), pyrrinol was 
syntbesized according to the Iiterature (Adamson, 
1949) and hexahydro-procyclidine was obtained 
by catalytic hydrogenation of pyrrinol. 
3. Results 
As shown in fig. 2, the four compounds in-
vestigated in this study inhibited [3H]NMS bind-
ing to the three musearlnie receptors in a manner 
consistent with competition for a si" · · · binding 
site (Hili coefficients were not signif. mtly differ-
ent from 1). 
The affinity of the procyclidine eutomer, (R)-
procyclidine, for M1 and M 4 receptors was greater 
than its affinity for M2 receptors (table 1 and fig . 
2). The procyclidine distomer, (S)-procyclidine, 
bad a similar affinity for the three subtypes (table 
1 and fig. 2). As a result, the eudismic index (pKi 
(eutomer) - pKi (distomer)) at M 1 and M 4 re· 
ceptors was greater than that at M2 receptors 
(table 1). 
Pyrrinol and hexahydro-procyclidine bad lower 
affinities than (R)-procyclidine, and higher affini-
ties than (S)-procyclidine, at the three subtypes 
(table 1 and fig. 2). 
Hexahydro-procyclidine bad the same receptor 
selectivity pattem as (R)-procyclidine. In contrast, 
pyrrinol was almost nonselective (table 1 and fig. 
2), as observed for (S)-procyclidine. 
The binding fr::~ ~nergies of the compounds 
studied in tiüs work and lileir differences are 
Comparison of pKi values a and free energies of binding (110) a (in kJ·mol- 1) of (R)-procyclidine. (S)-procyclidine. pyrrinol and 
hexahydro.procyclidine for musearlnie receptor subtypes M1, M2 and M 4• 
Muscarinic antagonist Mt (NB·OK 1) M2 (heart) M 4 (striatum) 
pKi; liG pKi; liG pKi; AG 
1) (R}-Procyclidine 8.4 47.95 7.3 41.68 8.1 46.24 
2) Pyrrinol 7.5 42.81 6.9 39.37 7.2 41.09 
3) Hexahydro.procyclidine 7.1 40.55 6.1 34.81 7.0 39.96 
4) (S)-Procyclidine 6.3 35.94 5.8 33.10 6.0 34.27 
1-4 ~ 2.1 12.01 1.5 8.58 2.1 11.97 
8 The pKi and AG values were calcu1ated as explained in Materials and methods (2.4, analysis of binding data). The standard 
deviation of pKi values was estimated at ±0.15 log units. 
b Eudisrnic index (difference of the pKi values) and differences between the free energies of binding of (R)- and (S)-procyclidine at 
each receptor subtype. 
100 
~ 
i 
:J 
0 50 lXI 
Ul 
::E 
z 
~ 
~ 
0 
1001 
50 
0 
Heart 
Hexahydro-
procyclichne 
\, (SJ -Procyclidine 
\/ 
' • .. 
-I ~--·-··-..~- .. -.................... STRIAH:a:yd:I0T~S 
'\ ~prDt1C1idlne 
lAI -ProtyCiidtne X ~ "-.. \.ISJ-Procychdine 
Pyrrtnol •.• "··. J 
·. . .. •· .. ,_ ... 
,-~~_ ..... g ___ .... e-.--_..-7-_",;":",j-,_s_---"'~_'""'s ..--..:'4 
[ORUG] (log M) 
Fig. 2. [3H)NMS competition curves in membrane.; from hu-
man neurobhastoma Nß.OK 1 cells (upper panel). rat beart 
(middle panel) and rat striatum (lower panel). eH]NMS bind· 
äng was measured in the absence or presence of (R}procycli-
dine (0). (S)-procyclidine (e), pyrrinol (.&) and hexahydropro. 
cyclidine <•>· as described in Materialsand methods. Average 
of three experiments perfonned in duplicate. 
quoted in tables 1 and 2. The difference between 
the binding free energies of (R)-procyclidine and 
hexahydro-procyclidine ( about 7 .kJ • mol- 1) was 
TABLE2 
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Fig. 3. Interaction pbarmacophores of (ll)-proc}'didine 
(eutomer) binding to four subsitcs of musearlnie receptors. 
very shnilar for the three receptors. In contrast, 
the difference between the binding free energies. of 
(R)-procyclidine and pyrrinol was smaller at 
cardiac M 2 Ülan at M1 or M4 receptors. The 
difference observed between the free binding en-
ergies of (R)- and (S) procyclidine corresponded 
to the sum of the differences between free binding 
energies of (R)-procyclidine and pyrrinol, and be~ 
tween (R)-procyclidine and hexahydro-procycli-
dine, at M 1, M 2 and M4 receptors. 
4. Discussion 
The fact that procyclidine binding was highly 
stereoselective indicates that at least three groups 
surrounding the asymmetrically substituted carl.,on 
atom contributed to overall drug binding affinity 
{fig. 3). The free energy of (R)-procyclidine bind ... 
ing c~., therefore be described by equation (3): 
.AG= ~G! + ßllGi. + y.1G3 + &lG4 (3} 
Differenc:es in free energies (kJ · mr' -t) for binding of (R}procyclidine. (S)-procyclidine. pyrrinoJ and hcxahydro-prOC)'.,;l.idii.~ i<J 
musearlnie rcceptor subtypes M~t i.llz auJ M4 • 
Musearlnie antagonist M1 (NB-OK 1) M2 (heart) M4 (striatum) 
(R).Procyclidine/pyninol + 5.14 + 2.31 + 5.15 
(R)-Procyelidinc/hexahydro-procyclidine + 7.40 + 6.87 + 6.28 
(R)-Procyclidine/(S)-procyclidine 
obsen·ed • + 12.01 + 8.58 + 11.97 
expected b + 12.54 +9.18 + 11.43 
• Differcnce betwt:en the free energies or the binding of (R)-procyelidine and (S).procyclidine at each receptor subtype. 
b Sum or the differences or the free energies of binding of (R)-procyclidinc and pyninot as v.·eß as of (R)-procyclidine al'ld 
hexahydro-procyclidine. 
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where .401, .402, J1G3 and .4G4 represent the free 
energy achievable by an optimal interaction of, 
respectively, the hydrophobic phenyl ring of the 
Iigand with receptor site 1, the cyclohexyl group 
with receptor site 2, the bydroxy group with recep-
tor site 3 and the prot"nated amino group with 
receptor site 4. The value of ~G should be as 
negative as possible to obtain high-affmity bind-
ing. Factors a, ß, y and 8 in equation 3 take into 
account the fact that al1 four groups are not 
necessarily simultaneously in optimal position to 
interact with reaptor sites 1 to 4 { at ß: y and 8 
values probably vary between 0 and 1, prc,vided 
that the corresponding group does not obstruct 
binding by steric hindrance). 
The protonated amino group of procyclidine 
(fig. 3} might conceivably contribute different in-
teractions with the fourth receptor subsite: an 
ion-ion interaction (Iigand + • ... - - - - - receptor), 
an ion-dipole interaction (Iigand + - - .. • • • recep .. 
tor) and a hydrogen bond (N--H----- -X-
receptor). The aveiage intrinsic binding energy of 
protonated nitrogenswas estimated at 11.5 kcal· 
mol- 1 (i.e. 48.1 kJ · mol-1; Andrews, 1986). This 
very important contrlbution to drug binding is 
Colnpatible with the Observation tbat all muscarinic 
antagonists possess a cationic group. lonic interac-
tions per se probably made an important contri· 
bution to binding, since the two enantiomers of 
the quatetnary ammonium derivative tricyclamol 
(with a pennanent charge and no N-H group), 
show higher affinities than procyclidine for the 
three receptors (unpublished results). 
The hydroxy group of (R)-procyclidine (fig. 3) 
probably forms a hydrogen bond with the third 
receptor subsite: desoxyprocyclidine (without an 
hydroxy group) showed the same low potency as 
(S)-procyciidine (ched by Lambrecht and 
Mutschler, 1986). Misplacing the hydroxy group 
of, for example, (S)-procyclidine might be even 
more unfavorable for binding than replacing it 
with a hydrogen atom, if the hydrogen bonds 
· formed with the solvent (water) must be broken to 
allow the drug-receptor interaction. 
The binding energy of ionic and hydrogen 
bonds depends strongly on the distance between 
the two atoms considered; furthermore, the orien-
tation of the 0-H bond respective to the electron· 
rieb acceptor atom also affects the hydrogen bond 
energy. Parameters y and 8 in equation 3 are 
therefore strongly dependent on the relative posi-
tions of the nitrogen, oxygen and OH-hydrogen 
atoms of the drug considered, relative to subsites 3 
and 4 of the receptor. 
The phenyl and cyclohexyl groups probably 
contribute to the binding energy by two other 
types of interactions: ( a) hydrophobic interac-
tionst when a nonpolar surface is r"!moved from 
water and (b) van der Waals interactions ( dipole-
dipole, dipole-induced dipole and induced dipole-
induced dipole interactions9 brought about by the 
close contact between nonbonded atoms or mole· 
cules). The hydrophobic interactions of the phenyl 
and cyclohexyl groups with receptor sites 1 and 2, 
respectively, are somewhat more independent than 
van der Waals interactions on the exact position 
of the two ring systems, relative to sites 1 and 2. 
Thereforet substituting the cyclohexyl and phenyl 
groups . of the musearlnie antagonist in hydro-
phobic receptor shes 1 and 2 might be less un-
favorable than sappressing the interaction of the 
hydroxy or ammonium groups of the antagonist 
with their respective receptor subsites 3 and 4. To 
test this hypothesis, we investigated the binding 
properties of two achiral molecules, in which the 
phenyl or cyclohexyl groups of (R)-procyclidine 
were replaced by a cyclohexyl or phenyl group. 
We assumed that increases in binding free energy9 
due to the loss of van der W aals interactions with 
receptor sites 1 and 2, should be additive provided 
that the ammonium and hydroxy groups <'f the 4 
ligands retain their normal binding position (fig. 
3). 1bis was indeed observed experimentally: the 
differences of binding free energies of (R)-pro-
cyclidine .,... pyrrinol and (R)-procyclidine .,... 
hexahydro-procyclidine were small, suggesting that 
steric hindrance did not prevent the interaction of 
the (larger) cyclohexyl group with the phenyl-pre-
ferring subsite (site 1). They were additive at M1, 
M 2 and M4 receptors (table 2). The stereoselectiv-
ity of these three receptors for procyclidine bind· 
ing apparent!y reflected poor interactions of the 
phenyl group at the cyclobexyl binding site and 
vice versa. 
Our results also gave valuable information con-
cerning the preferential binding of (R)-procycli-
dine to M1 and ~{4 receptors: the lower affmity of 
(R)-procyclidine for M2 sites was apparently due 
to a poorer fit of the cyclohexyl group in receptor 
subsite 2. This would indeed explain thc following 
Observations: 
(1) (R)-Procyclidine and the dicyclohexyl de-
rivative hexahydro-procyclidine were M1, M4 > 
M 2 selective as a cyclohexyl group was in contact 
with the 'cyclohexyl receptor site 2'. 
{2) (S)-Procyclidine and pyrrinol, the diphenyl 
derivative, were not selective as the cyclohexyl 
receptor site 2 was occupied by a phenyl group. 
(3) The affinity loss when replacing the 
cyclohexyl group of (R)-pr~Jfclidine by a phenyl 
group was much smaller at M 2 (2.31 kJ · mol- 1) 
tban at M1 and M 4 receptors (5.15 kJ · mol- 1 ). 
In conclusion, musearlnie M 1, M 2 and M4 re-
ceptors clearly discriminated between the two pro-
cyclidine enantiomers, and preferred (R)-pro-
cyclidine. This is in line with functional studies on 
guinea-pig ileum. (Tacke et al., 1986). The enanti-
oselectivity of cardiac M 2 receptors was lower 
than that of neuroblastoma M1 and striatum M4 
receptors. A systematic comparison of the binding 
properlies of the two procyclidine enantiomers 
and of the related achiral compounds pyrrinol and 
hexahydro-procyclidine suggested that the recep-
tors' stereoselectivity reflected the loss of van der 
W aals interactions of the hydrophobic receptor 
subsites recognizing the phenyl and cyclohexyl 
groups of the Iigand. The lower affinity and 
eudismic index of musearlnie M 2 receptors were 
due to the poorer interaction of their subsites with 
the cyclohexyl group (as compared to the 
cyclohexyl subsite of M1 or M4 receptors). 
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